CSIMarket
 


Galmed Pharmaceuticals Ltd   (GLMD)
Other Ticker:  
 
 

GLMD's EPS Net Growth by Quarter and Year

Galmed Pharmaceuticals Ltd 's EPS Net results by quarter and year




GLMD EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 0.71 1.32 1.35 0.97
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.71 1.32 1.35 0.97



GLMD EPS Net fourth quarter 2022 Y/Y Growth Comment
Galmed Pharmaceuticals Ltd reported drop in EPS Net in the fourth quarter 2022 by -46.21% to $ 0.71 , from the same quarter in 2021.
This represents worst decline in recent Company history.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher EPS Net growth. While Galmed Pharmaceuticals Ltd ' s EPS Net meltdown of -46.21% ranks overall at the positon no. 285 in the fourth quarter 2022.




GLMD EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -46.21 % -2.22 % 39.18 % 79.63 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -46.21 % -2.22 % 39.18 % 36.62 %

Financial Statements
Galmed Pharmaceuticals Ltd 's fourth quarter 2022 EPS Net $ 0.71 GLMD's Income Statement
Galmed Pharmaceuticals Ltd 's fourth quarter 2021 EPS Net $ 1.32 Quarterly GLMD's Income Statement
New: More GLMD's historic EPS Net Growth >>


GLMD EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -46.21 % -2.22 % 39.18 % 36.62 %




EPS Net fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #19
Overall #285

EPS Net Y/Y Growth Statistics
High Average Low
151.28 % 29.46 % -46.21 %
(Dec 31 2017)   (Dec 31 2022)
EPS Net fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #19
Overall #285
EPS Net Y/Y Growth Statistics
High Average Low
151.28 % 29.46 % -46.21 %
(Dec 31 2017)   (Dec 31 2022)

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Galmed Pharmaceuticals Ltd 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GLMD's IV. Quarter Q/Q EPS Net Comment


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GLMD's IV. Quarter Q/Q EPS Net Comment


Galmed Pharmaceuticals Ltd 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
Cumulative EPS Net 12 Months Ending $ 0.71 $ 0.00 $ 0.00 $ 0.00 $ 1.32
Y / Y EPS Net Growth (TTM) -46.21 % - - - -2.22 %
Year on Year EPS Net Growth Overall Ranking # 285 # 0 # 0 # 0 # 523
Seqeuential EPS Net Change (TTM) -46.21 % - - - -2.22 %
Seq. EPS Net Growth (TTM) Overall Ranking # 1223 # 0 # 0 # 0 # 523




Cumulative EPS Net growth Comment
Galmed Pharmaceuticals Ltd showed decline, but improvement compare to trailing twelve month EPS Net decrease in 0. If the fiscal year would end in Dec 31 2022, Galmed Pharmaceuticals Ltd 's annual EPS Net decline would be -46.21% year on year to $1 .

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 0 to 285.

EPS Net TTM Q/Q Growth Statistics
High Average Low
151.28 %
29.46 %
-46.21 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 19
Overall # 285

EPS Net TTM Y/Y Growth Statistics
High Average Low
151.28 %
29.46 %
-46.21 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 72
S&P 500 # 1223
Cumulative EPS Net growth Comment
Galmed Pharmaceuticals Ltd showed decline, but improvement compare to trailing twelve month EPS Net decrease in 0. If the fiscal year would end in Dec 31 2022, Galmed Pharmaceuticals Ltd 's annual EPS Net drop would be -46.21% year on year to $1 .

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 0 to 285.

EPS Net TTM Q/Q Growth Statistics
High Average Low
151.28 %
29.46 %
-46.21 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 19
Overall # 285

EPS Net TTM Y/Y Growth Statistics
High Average Low
151.28 %
29.46 %
-46.21 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 72
S&P 500 # 1223




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
GLMD's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for GLMD's Competitors
EPS Net Growth for Galmed Pharmaceuticals Ltd 's Suppliers
EPS Net Growth for GLMD's Customers

You may also want to know
GLMD's Annual Growth Rates GLMD's Profitability Ratios GLMD's Asset Turnover Ratio GLMD's Dividend Growth
GLMD's Roe GLMD's Valuation Ratios GLMD's Financial Strength Ratios GLMD's Dividend Payout Ratio
GLMD's Roa GLMD's Inventory Turnover Ratio GLMD's Growth Rates GLMD's Dividend Comparisons



Companies with similar EPS Net drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2022
Inmode Ltd -1.56%$ -1.563 
Encompass Health Corporation-3.08%$ -3.079 
Pro dex Inc -4.00%$ -4.000 
Vanda Pharmaceuticals Inc -4.28%$ -4.282 
Iradimed Corporation-5.39%$ -5.391 
Amedisys Inc -5.96%$ -5.958 
Vascular Biogenics Ltd -7.44%$ -7.437 
Eton Pharmaceuticals Inc -8.67%$ -8.671 
Amgen Inc -10.28%$ -10.281 
Lemaitre Vascular Inc -10.32%$ -10.323 
Polypid Ltd -10.53%$ -10.526 
Alcon inc -10.53%$ -10.526 
Intuitive Surgical Inc -10.57%$ -10.573 
Bristol myers Squibb Company-11.49%$ -11.487 
Envista Holdings Corporation-12.37%$ -12.366 
Steris Plc-12.68%$ -12.676 
Acadia Healthcare Company Inc -14.05%$ -14.050 
Uniqure N v -14.81%$ -14.812 
Stryker Corp-15.06%$ -15.064 
Qiagen N v -16.74%$ -16.742 
Pharming Group N v -17.39%$ -17.391 
Universal Health Services Inc -18.15%$ -18.149 
Orgenesis Inc -19.08%$ -19.076 
Merck and Co Inc -20.10%$ -20.103 
Chemed Corporation-20.96%$ -20.960 
Atrion Corporation-21.05%$ -21.051 
Baxter International Inc -23.80%$ -23.799 
Integer Holdings Corporation-24.27%$ -24.266 
Iqvia Holdings Inc -25.04%$ -25.039 
Syneos Health Inc -25.41%$ -25.409 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com